Three dimensional pharmacophore models can be considered as an ensemble of steric and electronic features in space, which are necessary to ensure intermolecular interaction with a specific target in order to trigger or to block biological activity [1]. By identifying these features, a 3D pharmacophore model can be built in order to screen multi-conformatorial databases with the aim to detect compounds matching the pharmacophoric hypothesis and subsequently submit them to a biological testing. Even if a 3D crystal structure is at hand, the creation of a reliable pharmacophore model remains a challenging task.
CavKA (Cavity Knowledge Acceleration), our own in-house strategy employs the information of Co-crystallised ligand-receptor complexes for an automatic pharmacophore creation. Ligand features interacting with the binding site are detected and Grid [2] force field information is additionally taken into account as to weight and prioritize the identified features in question, to transform them into a pharmacophore model without any user intervention.
Our method is compared to LigandScout [3] and a custom MOE [4] implementation, similar to LigandScout, two powerful standard tools. Both are identifying ligand-receptor interactions to highlight important ligand features to be selected for creating pharmacophore models automatically. The performance is evaluated in a retrospective screening on the FieldScreen [5] dataset outlining strengths, weaknesses and as well as similarities of each method for the scrutinized targets.
References
- IUPAC
- Grid 22a, molecular discovery . http://www.moldiscovery.com
- Ligandscout 3.0, inte:ligand . http://www.inteligand.com
- Moe 2009.10, chemcomp . http://www.chemcomp.com
- Cheeseright TJ, Mackey MD, Melville JM, Vinter JG. FieldScreen: virtual screening using molecular fields. Application to the DUD data set. J Chem Inf Model. 2008;48:2108–2117. doi: 10.1021/ci800110p. [DOI] [PubMed] [Google Scholar]
